Academic
Publications
Influence of Glioma's Multidrug Resistance Phenotype on 99m Tc-Tetrofosmin Uptake

Influence of Glioma's Multidrug Resistance Phenotype on 99m Tc-Tetrofosmin Uptake,10.1007/s11307-010-0369-y,Molecular Imaging and Biology,George A. Al

Influence of Glioma's Multidrug Resistance Phenotype on 99m Tc-Tetrofosmin Uptake   (Citations: 2)
BibTex | RIS | RefWorks Download
Purpose  Multidrug resistance (MDR) remains a major obstacle to successful chemotherapeutic treatment of cancer. Several chemotherapeutic and radiopharmaceutical agents are substrates of the pumps encoded by the MDR genes, and therefore, their accumulation is prevented. We evaluated in vivo whether [99mTc]tetrofosmin (99mTc-TF) uptake is influenced by the MDR profile of gliomas. Procedures  Eighteen patients with histologically confirmed glioma were included in the study. Brain single-photon emission computed tomography by 99mTc-TF was performed within a week prior to surgical excision, and the expression of MRP5 was assessed by immunohistochemistry. Radiotracer accumulation was assessed by a semiquantitative method, calculating the lesion-to-normal uptake ratio. Results  Using Spearman's ρ analysis, we found no correlation between tracer uptake expressed as lesion-to-normal and MRP5 expression. There was a significant correlation between glioma aggressiveness as assessed by Ki-67/MIB-1 and MRP5 expression. Conclusion  The present data suggest that 99mTc-TF uptake is not influenced by glioma's MDR phenotype. Thus, 99mTc-TF constitutes a suitable radiotracer for imaging gliomas.
Journal: Molecular Imaging and Biology - MOL IMAGING BIOL , vol. 13, no. 2, pp. 348-351, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: